Search

everythinglearnresearchcommunity

for

Search:↓

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

Regulatory T cells help hair growth by using the Cxcr4-Cxcl12 pathway.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

γδ T cells are essential for wound healing after poxvirus infection.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Immune cells are crucial for hair growth and preventing hair loss.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Deleting the p63 gene in certain cells causes problems in thymus development and severe hair loss in mice.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

Blocking the CXCL12–CXCR4 axis may help treat hair loss in alopecia.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.